Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

IVD (In Vitro Diagnostic) Testing World Markets 2015


News provided by

ReportsnReports

27 Jan, 2015, 18:20 GMT

Share this article

Share toX

Share this article

Share toX

DALLAS, January 27, 2015 /PRNewswire/ --

ReportsnReports.com offers IVD (In Vitro Diagnostic) Testing World Markets industry research report of 339 pages published in Jan 2015 under its healthcare market intelligence collection of its online research and data library.

In vitro diagnostic (IVD) testing is experiencing a revival fueled by a combination of technological improvements, cost pressures, reimbursement changes, rapid growth in molecular diagnostics and increasing interest in the genomics testing. Recent advances in molecular diagnostics technologies--including sequencing, PCR and microarray--are enabling greater sensitivity and precision in nucleic acid measurements, further expanding manufacturers' offerings. Complete report on IVD (In Vitro Diagnostic) Testing World Markets is available at http://www.reportsnreports.com/reports/330446-ivd-in-vitro-diagnostic-testing-world-markets.html .

This IVD market report is an overview of each major in vitro diagnostic testing segment, including: point of care testing (POCT), molecular diagnostics, chemistry, diabetes and glucose, immunoassay, hematology, coagulation, pathology, microbiology, histology and cytology, and blood banking. For each segment, this study examines the generally accepted clinical analytical activities in use today. Moreover, the analysis here discusses the potential benefits of the diagnostics techniques, as well as provides market size and future growth potential. Additionally, this report assesses the various business models, including CLIA-licensed specialty labs, general reference labs and reagent kit marketing. This study also examines hundreds of companies that are actively developing and marketing IVD testing products around the world. This report analyzes the size and growth of the important sectors of the diagnostics market, including the drivers and restraints that influence the various market segments, as well as the dollar volume of sales and market growth rates, both in the U.S. and worldwide.

Regionally, this in-vitro diagnostic testing market research provides summary analysis of the IVD high-growth market in U.S., Europe, South East Asia and Japan and BRIC (Brazil, Russia, India and China) countries. Key market drivers and barriers to growth are also discussed in this report.

Companies discussed in this IVD testing industry research's multiple sections and segments include Myriad Genetics (BRCA1 and BRCA2), Genomic Health (Oncotype DX), InterGenetics, Inc. 77, Clarient, Inc. (GE Healthcare), BioTheronostics , Agendia B.V. (MammaPrint), LabCorp, Quest Diagnostics, Abbott Diagnostics, Siemens, Roche, Beckman Coulter, Inc., bioMérieux, Ortho-Clinical Diagnostics, Ventana Medical Systems Inc. (part of Roche's Diagnostics Division), Dako (An Agilent Technologies Company), Aperio(Part of Leica Biosystems), Abbott Laboratories, Omnyx, LLC (Part of GE Healthcare) and Visiopharm.

174 Companies profiled in this in-vitro diagnostic testing market report cover A. Menarini, Abaxis, Inc., Abbott Laboratories, Accriva Diagnostics, Inc., Adaltis, AdnaGen, AdvanDx, Affymetrix, Inc., Agendia, Agilent Technologies, ALERE, INC., Alfa Scientific Designs, Inc., Alfa Wasserman, Inc., ALPHELYS, AMS, Ambry Genetics, ArcticDx, Inc., Ariosa Diagnostics, Inc., ARKRAY USA, Inc., Asuragen, Inc., Atlas Genetics, Atonomics A/S, AutoGenomics, Inc., Awareness Technology, Axxin, Bayer, BD, Beckman Coulter Genomics, Inc., Biocartis SA, BioCytex, Biodata (Microlink Engineering Systems), BioData Ltd., Biodesix, BioGenex Laboratories, Inc., BioFire Diagnostics, Inc. (Part of bioMérieux now), BioMedomics, bioMérieux, Biophor Diagnostics, Bio-Rad, Biosensia Ltd., Biosite Diagnostics (part of Alere), Biotage AB, bioTheranostics, Cancer Genetics, Inc., Caris Life Sciences, Cepheid, Celula, Inc., Chembio Diagnostics, Inc., Clarient, Coagusense, Inc., CombiMatrix Corporation, Curetis AG, Cyber Medical Ltd., Dako A/S (Agilent Technologies), Debiotech, DexCom , Diagnostica Stago, Inc., Diagnostica Stago S.A.S, Diagnostics for All, DiaSorin S.p.A., DxNA, LLC. , Echo Therapeutics, Eiken Chemical Company Limited, Enigma Diagnostics Limited, Epigenomics, Exact Sciences Corporation, Exagen Diagnostics, Inc., Exiqon, Exosome Diagnostics, FIFTY50 Medical, Inc., Fluidigm Corporation, Fujirebio Inc., GE Healthcare, Genera Biosystems, GenMark Diagnostics, Inc., Genomica S.A.U. , Genomic Health, Inc., Genomix Biotech, Genoptix, Inc., Gentag, Inc., Great Basin Corporation, Grifols, Haemonetics Corporation, Hologic Gen-Probe, Hutman Diagnostics, AG, Hy Laboratories Ltd., HYPHEN BioMed, Ikonisys Inc., Illumina, Inc. , Immunexpress Group, Infopia Co., Ltd., Innovative Biosensors, Inc., Integrity Applications, InterGenetics, Inc., Integrated Diagnostics, International Technidyne Corp (THORATEC CORP), Instrumentation Laboratory, IQuum, Inc.(acquired by Roche), iSense Corporation (subsidiary of BayerAG), JEOL Ltd., Johnson & Johnson, Kommanditgesellschaft Behnk Elektronik GmbH & Co., Kyowa Medex, LabCorp, Labor BioMedical Technologies GmbH (LABiTec), Leica Biosystems, Life Technologies Corporation, Luminex Corporation, Lumora Ltd., M-Biotech, MBio Diagnostics, Inc., MDxHealth, Medica Corporation, Inc., Medtronic, Menssana Research, Inc., Meridian Biosciences, Metaara Medical Technologies Inc., Miraculins Inc. , Mobidiag, Myriad Genetics, Inc , Nanosphere , Nanostring, Natera Inc., Neogenomics, Nipro Diagnostics, Nova Biomedical Corporation, Novartis, Novo Nordisk, Nuvera Biosciences, OraSure, Ortho Clinical Diagnostics (Formerly a Johnson & Johnson Company), Pfizer, Inc.. Phamatech, Inc., Pharma Supply, Inc., Polymedco, Prodigy Diabetes Care, LLC (formerly Diagnostic Devices, Inc.), Qiagen NV, Quidel Corporation, Radient Pharmaceuticals Corporation, Randox, Roche AG, Rosetta Genomics Ltd., Sanofi, Seegene, Sekisui Diagnostics, Sensors for Medicine and Science, Sequenom, Inc., Shimadzu Corporation, Siemens AG, Siemens Healthcare Diagnostics, Sienco Inc., Simple Diagnostics, SIRS-Lab, Smiths Medical, Source MDx, Spartan Bioscience, Spectrum Laboratories, Inc., Sysmex America, Inc., Technoclone Gmbh, Telcare, Thermo Fisher Scientific, Inc., TrimGen, TrovaGene, Trinity Biotech plc, U.S. Diagnostics, Universal Biosensors, Inc., Ventana, VeraLight, Veredus Laboratories, Veridex (a Johnson & Johnson company), Visiopharm, Wako, WILEX AG and ZS Genetics. Order a copy of this IVD testing report at http://www.reportsnreports.com/Purchase.aspx?name=330446 .

Few recent coagulation testing sector activities discussed in this research include Roche and Diagnostica Stago Parting Ways in Laboratory Coagulation, Roche Acquires Verum Diagnostica GmbH and Expands Coagulation Testing Product Line, Universal Biosensors and Siemens Collaborate on Advanced POC Coagulation Platform, Instrumentation Laboratory and Beckman Coulter concluded their Cross-Distribution Agreement, CoaguChek XS Personal Receives Reimbursement Approval for Self-Testing in Japan, Diagnostica Stago Launches Products for Measurement of Rivaroxaban, Diagnostic Stago Offers Three Factor VII Detection Methods, Diagnostica Stago Offers Three Procoagulant Microparticle Detection Methods, Diagnostica Stago S.A.S enters into Joint Research Agreement with Bristol-Myers Squibb, Trinity Biotech Sold its Worldwide Coagulation Business to the Stago Group, Alere aka Inverness Medical Innovations Acquired HemoSense, Inc. and Alere Announced Positive Results in Clinical Study Evaluating At-Home Coagulation Testing.

Explore more reports on the in-vitro diagnostics market as well as the IVD industry at http://www.reportsnreports.com/tags/ivd-market-research.html .

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.

Contact:  

Ritesh Tiwari / Priyank Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel:  +1-888-391-5441

sales@reportsandreports.com

Connect with Us: 

G+ / Google Plus: https://plus.google.com/u/0/111656568937629536321/posts  

Twitter: http://twitter.com/marketsreports

Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689

RSS / Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.